ONGERICIMAB
UNII X126G5DZ36

Substance Identification & Data

This profile provides standardized clinical and technical data for Ongericimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) X126G5DZ36.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2145096-91-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

X126G5DZ36

CAS Registry Number

2145096-91-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ONGERICIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C174940

National Cancer Institute reference terminology for clinical and research data.

INN ID

11188

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ongericimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ONGERICIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4, ANTI-(NEURAL APOPTOSIS-REGULATED CONVERTASE 1) (HUMAN MONOCLONAL JS002 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JS002 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENSPCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC1, NARC-1, PROPROTEIN CONVERTASE 9, PC9)), HUMANIZED MONOCLONAL ANTIBODY

JS002

ONGERICIMAB [INN]

ONGERICIMAB [WHO-DD]